Vol. 44 | No. 1 | January-June 2016 Back

Open Access

Prevention of Perioperative Cardiac Events Using Clonidine in Patients with Coronary Artery Disease Undergoing Noncardiac Surgery: A Meta-Analysis

Abstract

Background: Clonidine may help prevent cardiac events in patients with coronary artery disease (CAD) undergoing noncardiac surgery by sympatholysis. This study aims to provide a systematic review of randomized controlled trials (RCTs) that assessed the efficacy of low-dose clonidine in preventing cardiac events perioperatively. 

Methods: The authors independently searched the online sites of Medline, PubMed and the Cochrane Database of Systematic Reviews for RCTs involving human participants. The search terms clonidine, prevention, myocardial ischemia, myocardial infarction, and noncardiac surgery were used. 

Results: Five trials comprising 10,618 participants were analyzed for the efficacy of low-dose clonidine in preventing cardiac events among patients with CAD undergoing noncardiac surgery. Low dose clonidine significantly reduced the incidence of myocardial ischemia in patients undergoing noncardiac surgery (RR 0.64; 95% CI, 0.50, 0.81), but it was not associated with any significant reduction in the risk of myocardial infarction (RR 1.09; 95% CI, 0.94, 1.27), congestive heart failure (RR 1.24; 0.83, 1.85), cardiac arrhythmia (RR 1.10; 95% CI, 0.84, 1.45), and death (RR 0.93; 95 % CI, 0.67, 1.29). Significantly more patients in the clonidine group had hypotension compared to placebo (RR 1.28; 95 % CI, 1.22, 1.34). 

Conclusion: The meta-analysis suggests that perioperative low-dose clonidine reduced myocardial ischemia in patients at risk of CAD. However, it increased the risk of hypotension. The trend in reduction of mortality using low-dose clonidine was not statistically significant. The use of low-dose clonidine did not affect the risk of perioperative myocardial infarction, congestive heart failure and cardiac arrhythmia.

  1. Yin YC, Chow LH, Tsao CM, et al. Oral clonidine reduces myocardial ischemia in patients with coronary artery disease undergoing noncardiac surgery. Acta Anaesthesiol Sin. 2002;40:197–203. 
  2. Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1504– 1513. 
  3. Bouri S, Shun-Shin MJ, Cole GD, et al. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100:456–464. 
  4. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/ AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015;22:162–215. 
  5. Nishina K, Mikawa K, Uesugi T, et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology. 2002;96:323– 329. 
  6. Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology. 2004;101:284–293. 
  7. Ellis JE, Drijvers G, Pedlow S, et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg. 1994;79:1133–1140. 
  8. Stühmeier KD, Mainzer B, Cierpka J, et al. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology. 1996;85:706– 712. 

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.